Literature DB >> 9709273

The Canadian National Breast Screening Study: update on breast cancer mortality.

A B Miller1, T To, C J Baines, C Wall.   

Abstract

The Canadian National Breast Screening Study (CNBSS), conducted on women age 40-49, was designed to evaluate the efficacy of combined annual mammography and physical examination of the breasts in reducing breast cancer mortality in comparison to usual care (UC) controls. From January 1980 through March 1985, 25,214 women were individually randomized to the mammography/physical exam (MP) arm and 25,216 to the UC. The integrity of the randomization has been reviewed and confirmed to be unbiased. During an average, follow-up of 10.5 years from entry (range: 8.75-13 years), 82 women died from breast cancer in the MP arm and 72 in the UC, for a rate ratio of 1.14 (95% confidence interval: 0.83-1.56). All-cause mortality was almost identical comparing the two groups; the nonsignificant excess of breast cancer deaths in the MP arm was balanced by an excess of other cancer deaths in the UC arm.

Entities:  

Mesh:

Year:  1997        PMID: 9709273     DOI: 10.1093/jncimono/1997.22.37

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  12 in total

Review 1.  Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.

Authors:  J Ringash
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

Review 2.  Is clinical breast examination an acceptable alternative to mammographic screening?

Authors:  I Mittra; M Baum; H Thornton; J Houghton
Journal:  BMJ       Date:  2000-10-28

3.  Imagining the future of photoacoustic mammography.

Authors:  Simone van der Burg
Journal:  Sci Eng Ethics       Date:  2008-07-15       Impact factor: 3.525

4.  Informed consent for mammography screening: modelling the risks and benefits for American women.

Authors:  Tom Marshall
Journal:  Health Expect       Date:  2005-12       Impact factor: 3.377

5.  Why Was the US Preventive Services Task Force's 2009 Breast Cancer Screening Recommendation So Objectionable? A Historical Analysis.

Authors:  Barron H Lerner; Graham Curtiss-Rowlands
Journal:  Milbank Q       Date:  2022-09-23       Impact factor: 6.237

6.  Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2007-01-01

Review 7.  Is the false-positive rate in mammography in North America too high?

Authors:  Michelle T Le; Carmel E Mothersill; Colin B Seymour; Fiona E McNeill
Journal:  Br J Radiol       Date:  2016-06-08       Impact factor: 3.039

8.  Validation of a susceptibility, benefits, and barrier scale for mammography screening among Peruvian women: a cross-sectional study.

Authors:  Moises A Huaman; Kelly I Kamimura-Nishimura; Mariano Kanamori; Alejandro Siu; Andres G Lescano
Journal:  BMC Womens Health       Date:  2011-12-07       Impact factor: 2.809

Review 9.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

10.  At what age should screening mammography be recommended for Asian women?

Authors:  Junko Tsuchida; Masayuki Nagahashi; Omar M Rashid; Kazuaki Takabe; Toshifumi Wakai
Journal:  Cancer Med       Date:  2015-04-27       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.